Terms: = Ovarian cancer AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3 AND Prognosis
3596 results:
1. Preoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer.
Erturk A; Korkmaz E; Arslantas Z; Bekdemir S; Erturk NK
Rev Assoc Med Bras (1992); 2024; 70(5):e20231115. PubMed ID: 38775501
[TBL] [Abstract] [Full Text] [Related]
2. Dual‑regulated oncolytic adenovirus carrying
Zhao T; Ye W; Zhang R; Zhu X; Shi Q; Xu X; Chen W; Xu L; Meng Y
Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38757346
[TBL] [Abstract] [Full Text] [Related]
3. Small Nucleolar RNAs as Diagnostic and Prognostic Biomarkers in cancer: A Systematic Review and Meta-Analysis.
Gao L; Fan J; He J; Che X; Wang X; Han C
Technol Cancer Res Treat; 2024; 23():15330338241245939. PubMed ID: 38752263
[TBL] [Abstract] [Full Text] [Related]
4. CircAGFG1 Promotes ovarian cancer Progression Through the miR-409-3 p/ZEB1 Axis.
Luo J; Zhong H; Guo M; Xiao P; Cao R; Zhao M; Jing Y
Technol Cancer Res Treat; 2024; 23():15330338241252423. PubMed ID: 38752261
[TBL] [Abstract] [Full Text] [Related]
5. Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer.
Qin Y; Sheng Y; Ren M; Hou Z; Xiao L; Chen R
Sci Rep; 2024 May; 14(1):11133. PubMed ID: 38750159
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
Quan C; Chen X; Wen H; Wu X; Li J
BMC Cancer; 2024 May; 24(1):565. PubMed ID: 38711015
[TBL] [Abstract] [Full Text] [Related]
7. piR-1919609 Is an Ideal Potential Target for Reversing Platinum Resistance in ovarian cancer.
Yan Y; Tian D; Zhao B; Li Z; Huang Z; Li K; Chen X; Zhou L; Feng Y; Yang Z
Technol Cancer Res Treat; 2024; 23():15330338241249692. PubMed ID: 38706262
[TBL] [Abstract] [Full Text] [Related]
8. Impact of Bevacizumab on Clinical Outcomes in Patients With Platinum-resistant Relapsed ovarian cancer.
Seol A; Kim SI; Yoon HY; Lee M; Kim HS; Chung HH; Park NH; Song YS
In Vivo; 2024; 38(3):1338-1350. PubMed ID: 38688599
[TBL] [Abstract] [Full Text] [Related]
9. Mechanism of single-stranded DNA annealing by RAD52-RPA complex.
Liang CC; Greenhough LA; Masino L; Maslen S; Bajrami I; Tuppi M; Skehel M; Taylor IA; West SC
Nature; 2024 May; 629(8012):697-703. PubMed ID: 38658755
[TBL] [Abstract] [Full Text] [Related]
10. Exceptional lymph node recurrence of an unusual ovarian tumor 16 years later: a case report.
Sakhri S; Slimane M; Bouaziz H; Khessairi N; Boujelbene N; Ben Dhiab T
J Med Case Rep; 2024 Apr; 18(1):217. PubMed ID: 38654310
[TBL] [Abstract] [Full Text] [Related]
11. A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.
Cai X; Lin J; Liu L; Zheng J; Liu Q; Ji L; Sun Y
BMC Cancer; 2024 Apr; 24(1):515. PubMed ID: 38654239
[TBL] [Abstract] [Full Text] [Related]
12. Machine learning developed a fibroblast-related signature for predicting clinical outcome and drug sensitivity in ovarian cancer.
Fu W; Feng Q; Tao R
Medicine (Baltimore); 2024 Apr; 103(16):e37783. PubMed ID: 38640321
[TBL] [Abstract] [Full Text] [Related]
13. [Gonadoblastoma: Clinicopathological study and literature review of 3 cases].
Bao ML; Li X; Chen G; Li H; Chen W; Li HX
Zhonghua Nan Ke Xue; 2023 Jul; 29(7):634-638. PubMed ID: 38619412
[TBL] [Abstract] [Full Text] [Related]
14. Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT).
Kobayashi Y; Shimada M; Tamate M; Cho HW; Zhu J; Chou HH; Kajiyama H; Okamoto A; Aoki D; Kang S; Lee JW; Kim JW; Kim JH; Lin Z; Liu J; Wu X; Lai HC; Chang TC; Lai CH; Kim YM; Enomoto T
J Gynecol Oncol; 2024 May; 35(3):e87. PubMed ID: 38606827
[TBL] [Abstract] [Full Text] [Related]
15. Relationships of SIGLEC family-related lncRNAs with clinical prognosis and tumor immune microenvironment in ovarian cancer.
Jin X; Chen Y; Hu Q
Sci Rep; 2024 Mar; 14(1):7593. PubMed ID: 38556590
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
17. Review on the Role of BRCA Mutations in Genomic Screening and Risk Stratification of Prostate cancer.
Kalampokis N; Zabaftis C; Spinos T; Karavitakis M; Leotsakos I; Katafigiotis I; van der Poel H; Grivas N; Mitropoulos D
Curr Oncol; 2024 Feb; 31(3):1162-1169. PubMed ID: 38534919
[TBL] [Abstract] [Full Text] [Related]
18. PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
Güzel D; Terek C; Besler A; Serin G; Önal Z; Akman L; Göker E; Ali Şanli U; Zekioğlu O; Özdemir N; Özsaran A; Yildirim N
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():321-326. PubMed ID: 38518487
[TBL] [Abstract] [Full Text] [Related]
19. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
[TBL] [Abstract] [Full Text] [Related]
20. Identification of prognostic factors and construction of nomogram to predict cancer-specific survival for patients with ovarian granulosa cell tumors.
Zhang Y; Zhang Z; Ding X; Zhang K; Dai Y; Cheng W; Luo C
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2046. PubMed ID: 38507268
[TBL] [Abstract] [Full Text] [Related]
[Next]
